Combined immunotherapy with dendritic cells and cytokine-induced killer cells for solid tumors: a systematic review and meta-analysis of randomized controlled trials
Journal of Translational Medicine2024Vol. 22(1), pp. 1122–1122
Citations Over TimeTop 12% of 2024 papers
Wendi Jiang, Zhongda Wang, Qingquan Luo, Zhe Dai, Jialong Zhu, Xin Tao, Yiyang Xie, Yuanyang Du, Longwei Jiang, Xiaoyuan Chu, Gongbo Fu, Zengjie Lei
Abstract
DC-CIK immunotherapy shows promising efficacy and safety for solid tumors, improving survival rates and response rates. Further research is needed to optimize treatment regimens and identify predictive factors.
Related Papers
- → Hypothyroidism and levothyroxine therapy following bariatric surgery: a systematic review, meta-analysis, network meta-analysis, and meta-regression(2021)32 cited
- → Cytokine-induced killer cells/dendritic cells and cytokine-induced killer cells immunotherapy for the treatment of esophageal cancer(2021)14 cited
- → Cytokine-induced killer cells/dendritic cells-cytokine induced killer cells immunotherapy combined with chemotherapy for treatment of colorectal cancer in China: a meta-analysis of 29 trials involving 2,610 patients(2017)26 cited
- Efficacy of treating advanced non-small cell lung cancer with autologous cytokine-induced killer cells(2008)
- → Efficacy and Safety of Autologous Cytokine-Induced Killer (CIK) Cellular Immunotherapy Combined with Chemotherapy in Non-Small-Cell Carcinoma (NSCLC): A Meta-analysis(2024)